A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Atrial Fibrillation

Interventions

DRUG

OPC-108459

DRUG

Placebo

Trial Locations (1)

Kyushu Region